These positive earnings estimate revisions suggest that analysts are becoming more optimistic on GWPH’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that GW Pharmaceuticals could be a solid choice for investors.
Current Quarter Estimates for GWPH
In the past 30 days, 1 estimate has gone higher for GW Pharmaceuticals while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 58 cents a share 30 days ago, to a loss of 46 cents today, a move of 20.7%.
Current Year Estimates for GWPH
Meanwhile, GW Pharmaceuticals’ current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to no lower revision. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of $2.12 per share 30 days ago to a loss of $1.89 per share today, an increase of 10.8%.
Bottom Line
The stock has also started to move higher lately, adding 14.7% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment